GENERIC MEDICATIONS
May 18, 2018
Navigating the Generic Regulatory Landscape
Regulatory issues are increasingly challenging with the emergence of biosimilar medications and the proliferation of various tactics designed to extend market exclusivity.June 16, 2017
Getting a Handle on Generic-Drug Prices
June 23, 2015
Endo Acquires Par Pharmaceutical to Expand Generics
October 16, 2014
Purple Book Introduced for Biosimilars
May 21, 2013
FDA Blocks Generic Versions of Original OxyContin
January 23, 2013
Generic Drugs’ Safety Labeling Often Incorrect
November 20, 2012
Court Instructs FDA to Approve Watson’s Generic Actos
November 14, 2012
Par to Acquire 14 Generics
September 19, 2012
GPhA Receives Favorable Opinion on Shortage Initiative
September 19, 2012
Amarin Announces Approval of Generic for Hypertriglyceridemia
August 21, 2012
Austerity Pricing Tactics Support Generic Drug Growth in Europe
August 21, 2012
Impax Laboratories Enters Into Agreement With TOLMAR, Inc.
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.